Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 4, 2008, Pages 670-675

  Tzanavaras, Paraskevas D ^a   Themelis, Demetrius G ^a   Zotou, Anastasia ^a   Stratis, John ^a   Karlberg, Bo ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Dissolution; High performance liquid chromatography; Monolithic column; Pharmaceutical analysis; Selegiline hydrochloride

Indexed keywords

COSMOPRIL; SELEGILINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DISSOLUTION; DRUG DETERMINATION; DRUG INDUSTRY; DRUG SELECTIVITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; TABLET; ULTRAVIOLET RADIATION; VALIDATION STUDY;

REPRODUCIBILITY OF RESULTS; SELEGILINE; SOLUBILITY; TABLETS;

EID: 39149098448     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.039     Document Type: Article

References (25)

1. http://www.selegiline.com
2. Knoll J. Pharmacol. Toxicol. 82 (1998) 57-66
3. Science Daily, URL: http://www.sciencedaily.com.
4. Heinonen E.H., and Myllyla V. Drug Saf. 19 (1998) 11-22
5. Gudrun F. Drug Inf. J. 35 (2001) 865-874
6. Tzanavaras P.D., Verdoukas A., and Balloma T. J. Pharm. Biomed. Anal. 41 (2006) 437-441
7. Space J.S., Opio A.M., Nickerson B., Jiang H., Dumond M., and Berry M. J. Pharm. Biomed. Anal. 44 (2007) 1064-1071
8. Food and Drug Administration: Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms, US Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research, Rockville, MD, 1997.
9. Siewert M., Dressman J., Brown C.K., and Shah V.P. AAPS Pharm. Sci. Technol. 4 (2003) (Article 7)
10. Cabrera K., Lubda D., Eggenweiler H.-M., Minakuchi H., and Nakanishi K. J. High Resol. Chromatogr. 23 (2000) 93-102
11. K. Nakanishi, N. Soga, U.S. Patent No. 5,624,875, 1997.
12. Tzanavaras P.D., and Themelis D.G. J. Pharm. Biomed. Anal. 43 (2007) 1483-1487
13. Tzanavaras P.D., and Themelis D.G. J. Pharm. Biomed. Anal. 43 (2007) 1526-1530
14. El Deeb S., Preu L., and Watzig H. J. Pharm. Biomed. Anal. 44 (2007) 85-95
15. Lemr K., Jirovsky D., and Sevcik J. J. Liq. Chromatogr. Relat. Technol. 19 (1996) 3173-3191
16. Beaulier N., Cyr T.D., Graham S.J., and Lovering E.G. J. Assoc. Off. Anal. Chem. 74 (1991) 453-455
17. Nishida K., Itoh S., Inone N., Kudo K., and Ikeda N. J. Anal. Toxicol. 30 (2006) 232-237
18. Slawson M.H., Taccogno J.L., Foltz R.L., and Moody D.E. J. Anal. Toxicol. 26 (2002) 430-437
19. Sevcik K., Stransky Z., Ingelse B.A., and Lemr K. J. Pharm. Biomed. Anal. 14 (1996) 1089-1094
20. Szoko E., and Magyar K. J. Chromatogr. A 709 (1995) 157-162
21. Mahmood I., Neau S., and Mason W.D. J. Pharm. Biomed. Anal. 12 (1994) 895-899
22. Patrick K.S., Nguyen B.L., and McCallister J.D. J. Chromatogr. 121 (1992) 254-258
23. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (I.C.H.), Q2/R1 Validation of analytical procedures. Text and methodology, 1995.
24. Noory C., Tran N., Ouderkirk L., Brown S., Perry J., Lopez J., Colon M., Faberlle M., Henry K., Rorberg J., Ali S.N., and Shah V. Dissolut. Technol. 6 (1999) 6
25. Federation International Pharmaceutical (F.I.P.), F.I.P. guidelines for dissolution testing of solid oral products. Joint report of the section for official laboratories and medicines control services and the section of industrial pharmacists of the F.I.P., 1997.